Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer
Open Access
- 5 April 2024
- journal article
- review article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 69 (5) , 1562-1570
Abstract
Esophageal carcinoma (ESCA) is an aggressive solid tumor. The 5-year survival rate for patients with ESCA is estimated to be less than 20%, mainly due to tumor invasion and metastasis. Therefore, it is urgent to improve early diagnostic tools and effective treatments for ESCA patients. Tumor microenvironment (TME) enhances the ability of tumor cells to proliferate, migrate, and escape from the immune system, thus promoting the occurrence and development of tumor. TME contains chemokines. Chemokines consist of four major families, which are mainly composed of CC and CXC families. The main purpose of this review is to understand the CC and CXC chemokines and their receptors in ESCA, to improve the understanding of tumorigenesis of ESCA and determine new biomarkers for the diagnosis and prognosis of ESCA. We reviewed the literature on CC and CXC chemokines and their receptors in ESCA identified by PubMed database. This article introduces the general structures and functions of CC, CXC chemokines and their receptors in TME, as well as their roles in the progress of ESCA. Chemokines are involved in the development of ESCA, such as cancer cell invasion, metastasis, angiogenesis, and radioresistance, and are key determinants of disease progression, which have a great impact on patient prognosis and treatment response. In addition, a full understanding of their mechanism of action is essential to further verify that these chemokines and their receptors may serve as biomarkers or therapeutic targets of ESCA. Graphical Abstract The poor prognosis of esophageal cancer is related to the early invasion and metastasis of the tumor. Tumor-associated macrophages are highly correlated with the occurrence, development, severity, and prognosis of esophageal cancer in the tumor microenvironment. Studies have shown that tumor-associated macrophages and esophageal cancer cells in the esophageal cancer microenvironment can secrete a variety of chemokines. A comprehensive analysis of the literature on the relationship between esophageal cancer cells and chemokines found that the binding of these chemokines with corresponding receptors can regulate the growth, migration and invasion, angiogenesis, radiotherapy resistance and leukocyte invasion of the tumor.Keywords
Funding Information
- Leading talent project of scientific and technological innovation in Tianshan talents training plan of Xinjiang Uygur Autonomous Region ((2022TSYCLJ0031))
- Project from State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asia ((SKL-HIDCA-2022-14, SKL-HIDCA-2020-JZ2)
- Natural Science Foundation of Xinjiang (2022D01D69)
- Key Research and Development Project of the Xinjiang Uygur Autonomous Region (2020B03003-1)
- The study was partly supported by Natural Science Foundation of China ((82260568))
This publication has 77 references indexed in Scilit:
- Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signalingBiochemical and Biophysical Research Communications, 2022
- Oral Microbiota Variation: A Risk Factor for Development and Poor Prognosis of Esophageal CancerDigestive Diseases and Sciences, 2021
- Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin PathwayThe American Journal of Pathology, 2021
- CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD‐L1 via activation of STAT3 pathwayJournal of Cellular Physiology, 2020
- Chemokines and chemokine receptors: A new strategy for breast cancer therapyCancer Medicine, 2020
- Chemokines and their receptors as biomarkers in esophageal cancerEsophagus, 2019
- Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: A case–cohort study in JapanInternational Journal of Cancer, 2019
- Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patientsClinical and Experimental Medicine, 2019
- MCP2 activates NF‐κB signaling pathway promoting the migration and invasion of ESCC cellsCell Biology International, 2017
- Specific gene expression profiles are associated with a pathologic complete response to neoadjuvant therapy in esophageal adenocarcinomaThe American Journal of Surgery, 2017